Sectors

LINE
Lineage, Inc.
39.25
2 x 31.31
2 x 47.18
bid
ask
-
0.07
0.18%
2 @ 07:30 PM
39.50 +0.25 (0.64%)
Ytd12.14%
1y-6.35%
38.41
day range
39.52
31.33
52 week range
45.75
Open39.21Prev Close39.32Low38.41High39.52Mkt Cap9.84B
Vol1.56MAvg Vol943.44KEPS-0.72P/EN/AForward P/E-60.85
Beta0.90Short Ratio5.88Inst. Own34.59%Dividend2.13Div Yield5.42
Ex Div Date06-30Earning11-1150-d Avg42.35200-d Avg38.501yr Est45.11

LINE News

BlackRock Inc. Takes Position in Lineage, Inc. $LINE
defenseworld.net
BlackRock Inc. Takes Position in Lineage, Inc. $LINE

BlackRock Inc. bought a new position in shares of Lineage, Inc. (NASDAQ: LINE) during the second qua

benzinga.com
Piper Sandler Maintains Neutral on Lineage, Lowers Price Target to $44

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and lower

KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering
globenewswire.com
KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering

BOCA RATON, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- KARMAN LINE ACQUISITION CORP. (the “Company”), a

benzinga.com
RBC Capital Maintains Outperform on Lineage, Raises Price Target to $48

RBC Capital analyst Michael Carroll maintains Lineage (NASDAQ:LINE) with a Outperform and raises

benzinga.com
Citigroup Maintains Neutral on Lineage, Raises Price Target to $43

Citigroup analyst Nick Joseph maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price

Lineage Cell Therapeutics Q2 Earnings Call Highlights
marketbeat.com
Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline duri

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
businesswire.com
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.

Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcript
seekingalpha.com
Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcript

Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcript

Lineage Q2 Earnings Call Highlights
marketbeat.com
Lineage Q2 Earnings Call Highlights

Lineage NASDAQ: LINE reported second-quarter results that exceeded its internal expectations and con

Compared to Estimates, Lineage, Inc. (LINE) Q2 Earnings: A Look at Key Metrics
zacks.com
Compared to Estimates, Lineage, Inc. (LINE) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Lineage, Inc. (LINE) give a sense of how its business performed in

Lineage, Inc. (LINE) Beats Q2 FFO and Revenue Estimates
zacks.com
Lineage, Inc. (LINE) Beats Q2 FFO and Revenue Estimates

Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.76 per share, beating

benzinga.com
Lineage Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $1.361B Miss $1.362B Estimate

Lineage (NASDAQ:LINE) reported quarterly losses of $(0.13) per share which beat the analyst consensu

Lineage, Inc. Reports Second-Quarter 2026 Financial Results
businesswire.com
Lineage, Inc. Reports Second-Quarter 2026 Financial Results

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest glob

PREFORMED LINE PRODUCTS ANNOUNCES RECORD SECOND QUARTER 2026 FINANCIAL RESULTS
prnewswire.com
PREFORMED LINE PRODUCTS ANNOUNCES RECORD SECOND QUARTER 2026 FINANCIAL RESULTS

CLEVELAND, July 29, 2026 /PRNewswire/ -- Preformed Line Products Company (NASDAQ: PLPC) today report

VALUE LINE, INC. ANNOUNCES HIGHER FISCAL YEAR 2026 EARNINGS
globenewswire.com
VALUE LINE, INC. ANNOUNCES HIGHER FISCAL YEAR 2026 EARNINGS

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc., (NASDAQ: VALU) reported results for th

This CarMax Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday
benzinga.com
This CarMax Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday

Analysts upgraded KMX, CAKE, LINE, and WFRD, with price targets raised. Check out their ratings page

benzinga.com
Mizuho Upgrades Lineage to Outperform, Raises Price Target to $47

Mizuho analyst Vikram Malhotra upgrades Lineage (NASDAQ:LINE) from Neutral to Outperform and rais

Aurora Mobile's GPTBots.ai Enhances Customer Service Solution with Audio Agent and LINE Plugin 2.0
globenewswire.com
Aurora Mobile's GPTBots.ai Enhances Customer Service Solution with Audio Agent and LINE Plugin 2.0

SINGAPORE, July 23, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or

benzinga.com
Piper Sandler Maintains Neutral on Lineage, Raises Price Target to $46

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and raise

VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAM
globenewswire.com
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPUR

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ – VALU ) announced today that i

benzinga.com
UBS Maintains Neutral on Lineage, Raises Price Target to $45

UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price

Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan
marketbeat.com
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan

Lineage Cell Therapeutics NYSEAMERICAN: LCTX used a conference call to outline its manufacturing str

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
businesswire.com
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc

Lineage: Don't Mistake A Cyclical Slump For A Broken Business
seekingalpha.com
Lineage: Don't Mistake A Cyclical Slump For A Broken Business

Lineage remains a Buy, offering a margin of safety and re-rating potential despite near-term macro a

Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel
globenewswire.com
Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel

MIDDLEBURY, Ind., July 08, 2026 (GLOBE NEWSWIRE) -- Grand Design RV, the fast-growing innovator of t

Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
accessnewswire.com
Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VA

Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026
businesswire.com
Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE), announced that it will report its financ

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
businesswire.com
Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Su

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc

benzinga.com
Evercore ISI Group Maintains In-Line on Lineage, Raises Price Target to $47

Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and raises

benzinga.com
Truist Securities Maintains Buy on Lineage, Raises Price Target to $46

Truist Securities analyst Michael Lewis maintains Lineage (NASDAQ:LINE) with a Buy and raises the

benzinga.com
Morgan Stanley Maintains Equal-Weight on Lineage, Raises Price Target to $47

Morgan Stanley analyst Ronald Kamdem maintains Lineage (NASDAQ:LINE) with a Equal-Weight and rais

benzinga.com
Wells Fargo Maintains Equal-Weight on Lineage, Lowers Price Target to $36

Wells Fargo analyst Blaine Heck maintains Lineage (NASDAQ:LINE) with a Equal-Weight and lowers th

benzinga.com
Barclays Maintains Underweight on Lineage, Raises Price Target to $35

Barclays analyst Brendan Lynch maintains Lineage (NASDAQ:LINE) with a Underweight and raises the

benzinga.com
Evercore ISI Group Maintains In-Line on Lineage, Raises Price Target to $41

Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and raises

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

benzinga.com
Lineage Q1 EPS $(0.18) Misses $(0.14) Estimate, Sales $1.297B Miss $1.322B Estimate

Lineage (NASDAQ:LINE) reported quarterly losses of $(0.18) per share which missed the analyst consen

This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
benzinga.com
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on Adobe, AMD, Campbell's, Lineage, and WR Berkley. See

benzinga.com
Barclays Downgrades Lineage to Underweight, Lowers Price Target to $34

Barclays analyst Brendan Lynch downgrades Lineage (NASDAQ:LINE) from Equal-Weight to Underweight

Alpha Buying: When Insiders Step In Across the Market
benzinga.com
Alpha Buying: When Insiders Step In Across the Market

benzinga.com
Evercore ISI Group Maintains In-Line on Lineage, Lowers Price Target to $38

Evercore ISI Group analyst Steve Sakwa maintains Lineage (NASDAQ:LINE) with a In-Line and lowers

benzinga.com
Piper Sandler Maintains Neutral on Lineage, Lowers Price Target to $35

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and lower

benzinga.com
Goldman Sachs Maintains Buy on Lineage, Raises Price Target to $51

Goldman Sachs analyst Caitlin Burrows maintains Lineage (NASDAQ:LINE) with a Buy and raises the p

benzinga.com
Compass Point Initiates Coverage On Lineage with Buy Rating, Announces Price Target of $47

Compass Point analyst Rob Simone initiates coverage on Lineage (NASDAQ:LINE) with a Buy rating an

benzinga.com
Lineage Raises Quarterly Dividend From $0.5275 To $0.5325/Share

Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-con

benzinga.com
Scotiabank Maintains Sector Perform on Lineage, Raises Price Target to $42

Scotiabank analyst Greg McGinniss maintains Lineage (NASDAQ:LINE) with a Sector Perform and raise

benzinga.com
Truist Securities Maintains Buy on Lineage, Raises Price Target to $44

Truist Securities analyst Ki Bin Kim maintains Lineage (NASDAQ:LINE) with a Buy and raises the pr

benzinga.com
Citigroup Maintains Neutral on Lineage, Raises Price Target to $42

Citigroup analyst Nick Joseph maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price

benzinga.com
RBC Capital Maintains Outperform on Lineage, Raises Price Target to $44

RBC Capital analyst Michael Carroll maintains Lineage (NASDAQ:LINE) with a Outperform and raises

benzinga.com
Wells Fargo Maintains Equal-Weight on Lineage, Raises Price Target to $39

Wells Fargo analyst Blaine Heck maintains Lineage (NASDAQ:LINE) with a Equal-Weight and raises th

benzinga.com
Piper Sandler Maintains Neutral on Lineage, Raises Price Target to $43

Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and raise